Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Cipla slapped over Rs 1 crore fine by GST Authority

Cipla slapped with Rs 53L GST penalty for alleged TRAN-1 credit misuse, plans legal challenge

Farhat Nasim29 Nov 2024 6:18 PM IST

Mumbai: Drug major Cipla Limited has disclosed that the Office of the Principal Commissioner of Central Goods & Services Tax (GST) and Central...

Sun Pharma to Invest Rs 500 Cr in Assam Manufacturing Plant, 500+ Jobs Expected

Sun Pharma slapped Rs 76 crore fine by customs authorities

Farhat Nasim28 Nov 2024 3:14 PM IST

New Delhi: Sun Pharmaceutical Industries Limited (Sun Pharma) and its subsidiary, Sun Pharma Laboratories Limited, have been slapped with hefty...

HoD appointments of medical teachers- Rotational or Seniority based? SC to decide

Farhat Nasim28 Nov 2024 2:11 PM IST

New Delhi: The Supreme Court of India has issued an order to include the National Medical Commission (NMC) as a respondent in a case and sought its...

AIMSS Infrastructure Delays Trigger HP High Court Warning

Rising Misinformation But No Action: Govt's Moves On Misleading Health Ads In Limbo

Farhat Nasim27 Nov 2024 5:07 PM IST

New Delhi: The Union Health Ministry, in a response to an RTI dated November 7, disclosed that the proposed amendments to the Drugs and Magic...

PCI Directs Examining Authorities to Mandatorily Register on Portal by Feb 21

Pharmacists Must Now Mandatorily Verify Profiles with ABHA Number: PCI

Farhat Nasim26 Nov 2024 5:55 PM IST

New Delhi: In a move to integrate pharmacists into the Healthcare Professional Registry (HPR) under the Ayushman Bharat Digital Mission (ABDM), the...

NPPA Hikes Price of Cholesterol-Lowering Drug Atorvastatin

Farhat Nasim25 Nov 2024 6:23 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has recently revised the ceiling price of Atorvastatin 10 mg, a widely used...

SEBI Slaps Rs 25L Fine, 1-Year Market Ban on 2 Individuals For Insider Trading in Jagsonpal Pharma

Farhat Nasim25 Nov 2024 5:04 PM IST

NSE analyzed JPL trades, flagged patterns suggesting insider trading based on UPSI deemed price-sensitive, leading to action.

Torrent Pharma Gets Zero USFDA Observations for Dahej Plant

USFDA Inspection: Alembic Pharma gets form 483 with 5 procedural observations for Gujarat plant

Farhat Nasim25 Nov 2024 3:47 PM IST

The US Food and Drug Administration (USFDA) conducted inspection at Jarod-based solid oral formulation facility.

Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America

Aurobindo Pharma Partners with Global Pharma Major for Respiratory Product Development

Farhat Nasim25 Nov 2024 3:36 PM IST

As per the pact, both parties will co-exclusively commercialise the products.

Illegal Clinic Allegations Trigger Health Department Raid in Odisha

Raid: Telangana DCA Seizes Cefuroxime, Dexamethasone, Other Antibiotics, Steroids from Unlicensed Clinic

Farhat Nasim25 Nov 2024 3:26 PM IST

DCA officials also detected certain medicines circulating in the market with misleading claims on their labels.

Maharashtra Govt Seeks Rs 26.5 Crore for Track-and-Trace System

Himachal HC Orders Investigation into Spurious Drugs Production at Baddi Pharma Units

Farhat Nasim25 Nov 2024 2:43 PM IST

The complaint alleged that medicine Feracrylum API and 1 percent Feracrylum gel, which are homeostatic polymers, were not as per prescribed formula.

Abbott Volt Pulsed Field Ablation System bags USFDA approval for atrial fibrillation

Abbott's Plea Alleging NPPA Used Outdated PTR Data for Metoprolol Pricing Rejected by DoP

Farhat Nasim24 Nov 2024 11:00 AM IST

New Delhi: A review application filed by Abbott Healthcare, alleging that the National Pharmaceutical Pricing Authority (NPPA) used lower...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok